What does it take to understand cancer? And how do you probe the molecular landscape of your experimental model?

Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.

A guide for how and when to transition from the microarray to RNA-seq

A guide to glycan microarrays